FOR INVESTORS · SEED ROUND
Focus EduSolutions is conducting a $2M seed round for Hello, It's Me®, the purpose-built assistive technology platform closing the digital inclusion gap for 7 million adults with intellectual and developmental disabilities.
Request Investor Information→Founder, Hello, It's Me®
Seed · SAFE · $8M post-money cap
USE OF FUNDS
01
02
03
04
WHY HELLO, IT'S ME®
Market scale, clinical moat, revenue architecture, and proof of demand.
01 MARKET
$5.9B global TAM, $525M US SAM across 11 waiver states. Vastly underserved.
02 CLINICAL MOAT
The only Medicaid-funded IDD platform, governed by Dr. Karyn Harvey, Chief Clinical Architect, with a trauma-informed curriculum and care-plan integration.
03 REVENUE ARCHITECTURE
Government-funded recurring revenue at $1,200 ARPU. AT is 80–85% of revenue, diversified by coaching, vocational rehabilitation, and education.
04 PROOF OF DEMAND
Live Medicaid contract in Missouri. 175 billable IDD members. 20 care managers and providers. 7 coaches deployed. Clear path to $1.2M revenue.
Common investor questions about Hello, It's Me® and the seed round.
$5.9B global TAM, $525M US SAM across 11 waiver states. Vastly underserved with no Medicaid-funded digital platform purpose-built for IDD.
Government-funded recurring revenue at $1,200 ARPU per member per month through Medicaid HCBS waivers. Low churn, creditworthy government payer.
First Medicaid contract in Missouri. 175 billable IDD members. 20 care managers and providers. 7 coaches deployed. Clear path to $1.2M revenue through contracted and active opportunities.
Hello, It's Me® is the only Medicaid-funded IDD platform. Clinical moat through Dr. Karyn Harvey's framework. Deep care-plan integration. AT classification that competitors cannot replicate quickly.
Vik Aurora, CEO and Founder. Dr. Karyn Harvey, Chief Clinical Architect. Randeep Kaur. Shyam Nair.
$2M seed round, SAFE at $8M post-money cap. Allocated across: state expansion and sales, product and curricula, ops and compliance, and implementation and customer success.
REQUEST ACCESS
Complete the form to receive access to investor materials and schedule a briefing.
INVESTOR CONTACTS